Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:16033749rdf:typepubmed:Citationlld:pubmed
pubmed-article:16033749lifeskim:mentionsumls-concept:C0003232lld:lifeskim
pubmed-article:16033749lifeskim:mentionsumls-concept:C0008976lld:lifeskim
pubmed-article:16033749lifeskim:mentionsumls-concept:C0025664lld:lifeskim
pubmed-article:16033749lifeskim:mentionsumls-concept:C0543467lld:lifeskim
pubmed-article:16033749lifeskim:mentionsumls-concept:C0221259lld:lifeskim
pubmed-article:16033749lifeskim:mentionsumls-concept:C0034897lld:lifeskim
pubmed-article:16033749lifeskim:mentionsumls-concept:C1420453lld:lifeskim
pubmed-article:16033749pubmed:issue4lld:pubmed
pubmed-article:16033749pubmed:dateCreated2005-7-21lld:pubmed
pubmed-article:16033749pubmed:abstractTextTrachoma is the leading infectious cause of blindness worldwide. Surgery is available to correct trichiasis, which results from repeated episodes of infection with C. trachomatis. However, trichiasis recurrence rates post-surgery are very high. Methods for reducing post-surgical trichiasis recurrence need to be explored. This paper outlines the design of the Surgery for Trichiasis, Antibiotics to prevent Recurrence (STAR) Clinical Trial currently underway in Ethiopia. The STAR trial, funded by The National Eye Institute, is a randomized, controlled clinical trial of antibiotic use at time of trichiasis surgery, comparing topical tetracycline to single-dose azithromycin for the surgical patient and single-dose azithromycin for the surgical patient and all household members. The primary outcome is trichiasis recurrence at one-year. Data from this trial will be critical in helping to determine future policy on antibiotic treatment for C. trachomatis following surgery.lld:pubmed
pubmed-article:16033749pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16033749pubmed:languageenglld:pubmed
pubmed-article:16033749pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16033749pubmed:citationSubsetIMlld:pubmed
pubmed-article:16033749pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16033749pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16033749pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:16033749pubmed:statusMEDLINElld:pubmed
pubmed-article:16033749pubmed:monthAuglld:pubmed
pubmed-article:16033749pubmed:issn0928-6586lld:pubmed
pubmed-article:16033749pubmed:authorpubmed-author:WestSheila...lld:pubmed
pubmed-article:16033749pubmed:authorpubmed-author:MunozBeatrizBlld:pubmed
pubmed-article:16033749pubmed:authorpubmed-author:AlemayehuWond...lld:pubmed
pubmed-article:16033749pubmed:authorpubmed-author:MeleseMuluken...lld:pubmed
pubmed-article:16033749pubmed:authorpubmed-author:WestEmily SESlld:pubmed
pubmed-article:16033749pubmed:authorpubmed-author:ImeruAlemushAlld:pubmed
pubmed-article:16033749pubmed:issnTypePrintlld:pubmed
pubmed-article:16033749pubmed:volume12lld:pubmed
pubmed-article:16033749pubmed:ownerNLMlld:pubmed
pubmed-article:16033749pubmed:authorsCompleteYlld:pubmed
pubmed-article:16033749pubmed:pagination279-86lld:pubmed
pubmed-article:16033749pubmed:dateRevised2007-11-15lld:pubmed
pubmed-article:16033749pubmed:meshHeadingpubmed-meshheading:16033749...lld:pubmed
pubmed-article:16033749pubmed:meshHeadingpubmed-meshheading:16033749...lld:pubmed
pubmed-article:16033749pubmed:meshHeadingpubmed-meshheading:16033749...lld:pubmed
pubmed-article:16033749pubmed:meshHeadingpubmed-meshheading:16033749...lld:pubmed
pubmed-article:16033749pubmed:meshHeadingpubmed-meshheading:16033749...lld:pubmed
pubmed-article:16033749pubmed:meshHeadingpubmed-meshheading:16033749...lld:pubmed
pubmed-article:16033749pubmed:meshHeadingpubmed-meshheading:16033749...lld:pubmed
pubmed-article:16033749pubmed:meshHeadingpubmed-meshheading:16033749...lld:pubmed
pubmed-article:16033749pubmed:meshHeadingpubmed-meshheading:16033749...lld:pubmed
pubmed-article:16033749pubmed:meshHeadingpubmed-meshheading:16033749...lld:pubmed
pubmed-article:16033749pubmed:meshHeadingpubmed-meshheading:16033749...lld:pubmed
pubmed-article:16033749pubmed:meshHeadingpubmed-meshheading:16033749...lld:pubmed
pubmed-article:16033749pubmed:meshHeadingpubmed-meshheading:16033749...lld:pubmed
pubmed-article:16033749pubmed:meshHeadingpubmed-meshheading:16033749...lld:pubmed
pubmed-article:16033749pubmed:meshHeadingpubmed-meshheading:16033749...lld:pubmed
pubmed-article:16033749pubmed:meshHeadingpubmed-meshheading:16033749...lld:pubmed
pubmed-article:16033749pubmed:meshHeadingpubmed-meshheading:16033749...lld:pubmed
pubmed-article:16033749pubmed:year2005lld:pubmed
pubmed-article:16033749pubmed:articleTitleSurgery for Trichiasis, Antibiotics to prevent Recurrence (STAR) Clinical Trial methodology.lld:pubmed
pubmed-article:16033749pubmed:affiliationDana Center for Preventive Ophthalmology, Johns Hopkins University, Baltimore, MD 21205, USA. ewest@jhsph.edulld:pubmed
pubmed-article:16033749pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:16033749pubmed:publicationTypeComparative Studylld:pubmed
pubmed-article:16033749pubmed:publicationTypeResearch Support, U.S. Gov't, P.H.S.lld:pubmed
pubmed-article:16033749pubmed:publicationTypeResearch Support, N.I.H., Extramurallld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:16033749lld:pubmed